rs41290587

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_003118.4(SPARC):​c.733G>A​(p.Gly245Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00564 in 1,613,588 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0043 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0058 ( 30 hom. )

Consequence

SPARC
NM_003118.4 missense, splice_region

Scores

1
4
14
Splicing: ADA: 0.0007721
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 7.35
Variant links:
Genes affected
SPARC (HGNC:11219): (secreted protein acidic and cysteine rich) This gene encodes a cysteine-rich acidic matrix-associated protein. The encoded protein is required for the collagen in bone to become calcified but is also involved in extracellular matrix synthesis and promotion of changes to cell shape. The gene product has been associated with tumor suppression but has also been correlated with metastasis based on changes to cell shape which can promote tumor cell invasion. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.017677844).
BP6
Variant 5-151666362-C-T is Benign according to our data. Variant chr5-151666362-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 785151.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=5, Uncertain_significance=1}.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SPARCNM_003118.4 linkuse as main transcriptc.733G>A p.Gly245Arg missense_variant, splice_region_variant 8/10 ENST00000231061.9 NP_003109.1
SPARCNM_001309444.2 linkuse as main transcriptc.733G>A p.Gly245Arg missense_variant, splice_region_variant 8/10 NP_001296373.1
SPARCNM_001309443.2 linkuse as main transcriptc.730G>A p.Gly244Arg missense_variant, splice_region_variant 8/10 NP_001296372.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SPARCENST00000231061.9 linkuse as main transcriptc.733G>A p.Gly245Arg missense_variant, splice_region_variant 8/101 NM_003118.4 ENSP00000231061 P1
SPARCENST00000520687.1 linkuse as main transcriptn.336G>A splice_region_variant, non_coding_transcript_exon_variant 2/42
SPARCENST00000538026.5 linkuse as main transcript downstream_gene_variant 5 ENSP00000440127

Frequencies

GnomAD3 genomes
AF:
0.00434
AC:
661
AN:
152196
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00159
Gnomad AMI
AF:
0.0230
Gnomad AMR
AF:
0.00321
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00725
Gnomad OTH
AF:
0.00382
GnomAD3 exomes
AF:
0.00431
AC:
1080
AN:
250490
Hom.:
5
AF XY:
0.00436
AC XY:
591
AN XY:
135430
show subpopulations
Gnomad AFR exome
AF:
0.00160
Gnomad AMR exome
AF:
0.00501
Gnomad ASJ exome
AF:
0.00130
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00223
Gnomad FIN exome
AF:
0.00106
Gnomad NFE exome
AF:
0.00642
Gnomad OTH exome
AF:
0.00833
GnomAD4 exome
AF:
0.00578
AC:
8446
AN:
1461276
Hom.:
30
Cov.:
31
AF XY:
0.00573
AC XY:
4166
AN XY:
726940
show subpopulations
Gnomad4 AFR exome
AF:
0.00108
Gnomad4 AMR exome
AF:
0.00537
Gnomad4 ASJ exome
AF:
0.00134
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00239
Gnomad4 FIN exome
AF:
0.000936
Gnomad4 NFE exome
AF:
0.00669
Gnomad4 OTH exome
AF:
0.00663
GnomAD4 genome
AF:
0.00433
AC:
660
AN:
152312
Hom.:
3
Cov.:
33
AF XY:
0.00396
AC XY:
295
AN XY:
74470
show subpopulations
Gnomad4 AFR
AF:
0.00159
Gnomad4 AMR
AF:
0.00320
Gnomad4 ASJ
AF:
0.000576
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00207
Gnomad4 FIN
AF:
0.00104
Gnomad4 NFE
AF:
0.00725
Gnomad4 OTH
AF:
0.00378
Alfa
AF:
0.00588
Hom.:
7
Bravo
AF:
0.00414
TwinsUK
AF:
0.00431
AC:
16
ALSPAC
AF:
0.00545
AC:
21
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00698
AC:
60
ExAC
AF:
0.00451
AC:
548
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00726
EpiControl
AF:
0.00700

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2024SPARC: BS2 -
Likely benign, criteria provided, single submitterclinical testingGeneDxNov 05, 2021- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 28, 2022The c.733G>A (p.G245R) alteration is located in exon 8 (coding exon 7) of the SPARC gene. This alteration results from a G to A substitution at nucleotide position 733, causing the glycine (G) at amino acid position 245 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Osteogenesis imperfecta Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenMar 29, 2022- -
SPARC-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 08, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.51
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
0.030
CADD
Benign
21
DANN
Benign
0.093
DEOGEN2
Benign
0.17
T
Eigen
Benign
-0.22
Eigen_PC
Benign
-0.032
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.047
D
MetaRNN
Benign
0.018
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.34
N
MutationTaster
Benign
1.0
D
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
4.2
N
REVEL
Benign
0.28
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.36
B
Vest4
0.92
MutPred
0.59
Loss of helix (P = 0.0068);
MVP
0.37
MPC
0.76
ClinPred
0.043
T
GERP RS
5.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.43
gMVP
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00077
dbscSNV1_RF
Benign
0.088
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41290587; hg19: chr5-151045923; COSMIC: COSV50558513; COSMIC: COSV50558513; API